Total Payments
$4.1M
2024 Payments
$611,781
Companies
56
Transactions
5,178
Medicare Patients
101
Medicare Billing
$12,291
Payment Breakdown by Category
Other$3.0M (72.7%)
Travel$723,422 (17.5%)
Consulting$323,328 (7.8%)
Food & Beverage$81,026 (2.0%)
Education$780.19 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2.8M | 850 | 67.9% |
| Travel and Lodging | $723,422 | 2,536 | 17.5% |
| Consulting Fee | $323,328 | 104 | 7.8% |
| Honoraria | $128,515 | 44 | 3.1% |
| Food and Beverage | $81,026 | 1,604 | 2.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $68,671 | 22 | 1.7% |
| Education | $780.19 | 16 | 0.0% |
| Entertainment | $238.76 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $715,364 | 856 | $0 (2024) |
| Astellas Pharma US Inc | $536,410 | 444 | $0 (2024) |
| EMD Serono, Inc. | $468,062 | 475 | $0 (2024) |
| Incyte Corporation | $435,142 | 791 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $352,570 | 493 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $249,294 | 317 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $247,845 | 317 | $0 (2021) |
| Janssen Biotech, Inc. | $208,522 | 340 | $0 (2024) |
| Merck Sharp & Dohme LLC | $184,206 | 143 | $0 (2024) |
| PharmaEssentia USA Corporation | $176,243 | 208 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $611,781 | 695 | EMD Serono, Inc. ($124,638) |
| 2023 | $705,960 | 828 | Merck Sharp & Dohme LLC ($101,272) |
| 2022 | $725,877 | 921 | EMD Serono, Inc. ($101,619) |
| 2021 | $522,672 | 679 | Incyte Corporation ($118,882) |
| 2020 | $349,389 | 367 | PFIZER INC. ($92,839) |
| 2019 | $563,028 | 794 | PFIZER INC. ($171,119) |
| 2018 | $369,517 | 512 | PFIZER INC. ($119,233) |
| 2017 | $287,093 | 382 | PFIZER INC. ($116,166) |
All Payment Transactions
5,178 individual payment records from CMS Open Payments — Page 1 of 208
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Geron Corporation | RYTELO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,560.00 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | Cash or cash equivalent | $58.98 | General |
| Category: Oncology | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | Cash or cash equivalent | $20.14 | General |
| Category: Oncology | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | Cash or cash equivalent | $20.00 | General |
| Category: Oncology | ||||||
| 12/20/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | Cash or cash equivalent | $13.15 | General |
| Category: Oncology | ||||||
| 12/18/2024 | EMD Serono, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,210.00 | General |
| 12/18/2024 | Incyte Corporation | MONJUVI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Geron Corporation | RYTELO (Drug) | Travel and Lodging | In-kind items and services | $1,431.00 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/17/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/16/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,360.00 | General |
| Category: Oncology | ||||||
| 12/16/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | Cash or cash equivalent | $7.90 | General |
| Category: Oncology | ||||||
| 12/12/2024 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $891.14 | General |
| 12/12/2024 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $710.95 | General |
| 12/12/2024 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $262.88 | General |
| 12/11/2024 | Geron Corporation | RYTELO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,280.00 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,125.00 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Incyte Corporation | MONJUVI (Drug), JAKAFI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: Oncology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $162.85 | General |
| Category: Oncology | ||||||
| 12/08/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $105.63 | General |
| 12/08/2024 | Pharming Healthcare, Inc. | RUCONEST (Biological) | Food and Beverage | Cash or cash equivalent | $50.75 | General |
| Category: BIOLOGIC | ||||||
| 12/07/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,270.00 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | Cash or cash equivalent | $133.00 | General |
| Category: Oncology | ||||||
| 12/07/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $83.69 | General |
| Category: Oncology | ||||||
| 12/07/2024 | Geron Corporation | RYTELO (Drug) | Food and Beverage | In-kind items and services | $43.19 | General |
| Category: MYELODYSPLASTIC SYNDROME | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 18 | 27 | $6,750 | $2,407 |
| 2022 | 1 | 19 | 25 | $6,250 | $2,160 |
| 2021 | 1 | 23 | 36 | $9,000 | $3,085 |
| 2020 | 2 | 41 | 56 | $14,544 | $4,640 |
Total Patients
101
Total Services
144
Medicare Billing
$12,291
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 27 | $6,750 | $2,407 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 25 | $6,250 | $2,160 | 34.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 36 | $9,000 | $3,085 | 34.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 40 | $10,000 | $2,915 | 29.2% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 14 | 16 | $4,544 | $1,724 | 37.9% |
About Dr. Amit Mehta, M.D
Dr. Amit Mehta, M.D is a Hematology & Oncology healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1740460377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Mehta, M.D has received a total of $4.1M in payments from pharmaceutical and medical device companies, with $611,781 received in 2024. These payments were reported across 5,178 transactions from 56 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2.8M).
As a Medicare-enrolled provider, Mehta has provided services to 101 Medicare beneficiaries, totaling 144 services with total Medicare billing of $12,291. Data is available for 4 years (2020–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Cary, NC
- Active Since 11/12/2007
- Last Updated 03/01/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1740460377
Products in Payments
- ELIQUIS (Drug) $547,745
- XTANDI (Drug) $418,880
- MONJUVI (Drug) $383,380
- Tavalisse (Drug) $290,368
- FERAHEME (Drug) $247,845
- Xtandi (Drug) $210,996
- Bavencio (Drug) $194,077
- ERLEADA (Drug) $181,381
- BESREMI (Drug) $176,243
- FOTIVDA (Drug) $154,980
- KEYTRUDA (Biological) $137,854
- BAVENCIO (Drug) $133,580
- JEVTANA (Drug) $75,460
- Bavencio (Biological) $68,537
- JOENJA (Drug) $60,322
- Rezlidhia (Drug) $57,502
- TALZENNA (Drug) $56,220
- JAKAFI (Drug) $54,853
- MONOFERRIC (Drug) $52,815
- INLYTA (Drug) $47,278
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Cary
Suzanne Kirby, Md, MD
Hematology & Oncology — Payments: $4,034
Hematology & Oncology $4,034
Charles Eisenbeis, Md, MD
Hematology & Oncology — Payments: $131.63
Hematology & Oncology $131.63
Ms. Amanda Sherrod, Md, MD
Hematology & Oncology — Payments: $76.62
Hematology & Oncology $76.62
Maha Elkordy, M.d, M.D
Hematology & Oncology — Payments: $10.93
Hematology & Oncology $10.93
Paramjeet Singh, M.d, M.D
Hematology & Oncology
Hematology & Oncology
Sheila Shine, N.p, N.P
Hematology & Oncology
Hematology & Oncology